855930-17-5

Basic information

• Product Name: N-acetyl-1-nitro-6-bromonaphthalene
• CAS NO: 855930-17-5
• Molecular Weight: 309.119
• Mol File: 855930-17-5.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: N-acetyl-1-nitro-6-bromonaphthalene(CAS DataBase Reference)
• NIST Chemistry Reference: N-acetyl-1-nitro-6-bromonaphthalene(855930-17-5)
• EPA Substance Registry System: N-acetyl-1-nitro-6-bromonaphthalene(855930-17-5)

Safety Data

• Hazardous Substances Data: 855930-17-5(Hazardous Substances Data)

Upstream product

• 591253-73-5 6-bromo-1-aminonaphthalene 
• 7499-66-3 6-Bromonaphthalen-2-amine 
• 71590-31-3 6-bromo-2-aminonaphthalene hydrochloride 
• 5773-80-8 6-bromo-2-naphthoic acid 
• 71590-32-4 N-(6-bromo-[2]naphthyl)-acetamide 

Downstream Products

• 1241377-74-1 6-bromo-naphthalene-1,2-diamine 
• 1334312-52-5 MK-8325 
• 1334314-20-3 C₄₃H₅₄N₈O₆Si 
• 1334313-80-2 C₂₉H₃₂N₆Si 
• 1334313-79-9 C₃₉H₄₈N₆O₄Si 
• 131707-40-9 6-bromo-1-nitronaphthalen-2-amine 

Relevant articles and documents

Industrial preparation method of 6-bromonaphthalene-1, 2-diamine

The invention discloses an industrial preparation method of 6-bromonaphthalene-1, 2-diamine. The method comprises the following steps of: S1, making a compound III react with acetic anhydride in the presence of alkali and a catalyst to obtain a compound IV; S2, in the presence of acetic anhydride and nitric acid, taking acetic acid as a reaction solvent, performing reacting and purifying on the compound IV obtained in the step S1 to generate a compound V; S3, adding the compound V obtained in the above step into a solvent for dissolving the compound V, then adding a metal reducing agent and an ammonium chloride solution, heating to carry out a reaction for 6h, performing centrifugal filtering after finishing the reaction to obtain a filtrate, washing the filtrate with a sodium chloride solution, and performing concentrating to obtain a compound VI; and S4, adding the compound VI obtained in the previous step into a methanol solution, dropwise adding strong acid, replacing the solvent after finishing the reaction, performing crystallizing and filtering to obtain a compound 8. According to the method, the process is optimized, large-scale production can be achieved, applied materials are all commercial reagents, the cost is reduced, and the operation convenience is improved.

COMPOUNDS AS HEPATITIS C VIRUS INHIBITORS AND PHARMACEUTICAL USES THEREOF

The invention provides compounds as hepatitis C virus inhibitors and pharmaceutical uses thereof. Specifically, the invention provides compounds of Formula (I) or a stereoisomer, a tautomer, an enantiomer, an N-oxide, a hydrate, a solvate, a metabolite, a

FUSED TRICYCLIC COMPOUNDS AND DERIVATIVES THEREOF USEFUL FOR THE TREATMENT OF VIRAL DISEASES

The present invention relates to novel fused tricyclic compounds, compositions comprising at least one fused tricyclic compound, and methods of using fused tricyclic compounds for treating or preventing a viral infection or a virus-related disorder in a patient.